These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8576842)

  • 21. Population Pharmacokinetics and Dose Optimization of Teicoplanin during Venoarterial Extracorporeal Membrane Oxygenation.
    Wi J; Noh H; Min KL; Yang S; Jin BH; Hahn J; Bae SK; Kim J; Park MS; Choi D; Chang MJ
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of software for data analysis by therapeutic drug monitoring of teicoplanin, a glycopeptide antibiotic].
    Niwa T; Tokuma Y; Ito T; Kimura J; Tabata K; Takagi A
    Jpn J Antibiot; 2004 Aug; 57(4):413-9. PubMed ID: 15535042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Teicoplanin pharmacokinetics in pediatric patients.
    Dufort G; Ventura C; Olivé T; Ortega JJ
    Pediatr Infect Dis J; 1996 Jun; 15(6):494-8. PubMed ID: 8783345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme.
    Lamont E; Seaton RA; Macpherson M; Semple L; Bell E; Thomson AH
    J Antimicrob Chemother; 2009 Jul; 64(1):181-7. PubMed ID: 19411678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of pharmacokinetics of individual teicoplanin components in patients.
    Hanada K; Ikari S; Koukaki Y; Utena A; Kimura T; Hamano K; Ariki H; Masuhara K; Ogata H
    Biol Pharm Bull; 2007 May; 30(5):952-4. PubMed ID: 17473441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of teicoplanin in an ICU population of children and infants.
    Lukas JC; Karikas G; Gazouli M; Kalabalikis P; Hatzis T; Macheras P
    Pharm Res; 2004 Nov; 21(11):2064-71. PubMed ID: 15587929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of teicoplanin in the treatment of endocarditis caused by gram-positive bacteria.
    Presterl E; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 1993 May; 31(5):755-66. PubMed ID: 8335503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative efficacy of teicoplanin and cefazolin for cardiac operation prophylaxis in 3027 patients. The ESPRIT Group.
    Saginur R; Croteau D; Bergeron MG
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1120-30. PubMed ID: 11088036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age- and gender-related differences in teicoplanin levels in paediatric patients.
    Strenger V; Hofer N; Rödl S; Hönigl M; Raggam R; Seidel MG; Dornbusch HJ; Sperl D; Lackner H; Schwinger W; Sovinz P; Benesch M; Urlesberger B; Urban C
    J Antimicrob Chemother; 2013 Oct; 68(10):2318-23. PubMed ID: 23702837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of teicoplanin in patients undergoing chronic haemodialysis.
    Papaioannou MG; Marinaki S; Pappas M; Stamatiadis D; Giamarellos-Bourboulis EJ; Giamarellou H; Stathakis C
    Int J Antimicrob Agents; 2002 Mar; 19(3):233-6. PubMed ID: 11932147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loading dose required to achieve rapid therapeutic teicoplanin trough plasma concentration in patients with multidrug-resistant gram-positive infections.
    Wang JT; Liao HI; Wu Lin FL; Chang SC
    Basic Clin Pharmacol Toxicol; 2012 May; 110(5):416-20. PubMed ID: 22309355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
    Campoli-Richards DM; Brogden RN; Faulds D
    Drugs; 1990 Sep; 40(3):449-86. PubMed ID: 2146108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetics of teicoplanin in varying degrees of renal function.
    Lam YW; Kapusnik-Uner JE; Sachdeva M; Hackbarth C; Gambertoglio JG; Sande MA
    Clin Pharmacol Ther; 1990 May; 47(5):655-61. PubMed ID: 2140543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infective endocarditis and glycopeptides.
    Pittet D; Harding I
    J Infect; 1998 Sep; 37(2):127-35. PubMed ID: 9821086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetic analysis of dalbavancin, a novel lipoglycopeptide.
    Buckwalter M; Dowell JA
    J Clin Pharmacol; 2005 Nov; 45(11):1279-87. PubMed ID: 16239361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing doses.
    Del Favero A; Patoia L; Rosina R; Buniva G; Danese A; Bernareggi A; Molini E; Cavenaghi L
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2551-7. PubMed ID: 1839759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of teicoplanin in man after intravenous administration.
    Traina GL; Bonati M
    J Pharmacokinet Biopharm; 1984 Apr; 12(2):119-28. PubMed ID: 6238156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Teicoplanin, a new antibiotic effective against gram-positive bacterial infections of the skin and soft tissues.
    Bochud-Gabellon I; Regamey C
    Dermatologica; 1988; 176(1):29-38. PubMed ID: 2962889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and pharmacokinetics of teicoplanin in hemodialysis patients.
    Beckers B; Brodersen HP; Stolpmann RM; Jansen G; Larbig D
    Infection; 1993; 21(1):71-4. PubMed ID: 8449588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.